Skip to main content
. 2020 May 20;155(7):607–615. doi: 10.1001/jamasurg.2020.1040

Table 1. Cohort Characteristics by Surgeon Generations.

Variables Generation, No. (%)
First (n = 258) Second (n = 151) Third (n = 82) P valuea
Preoperative characteristics
Age, mean (SD), y 67.3 (11.7) 66.3 (11.1) 66.9 (10.0) .52
Female 121 (46.9) 71 (47.0) 34 (41.5) .66
Prior abdominal surgery 143 (55.4) 85 (56.3) 37 (45.1) .21
ASA score (≥3) 202 (78.3) 133 (88.1) 69 (84.1) .04
BMI, mean (SD) 27.7 (5.4) 28.1 (6.3) 26.2 (5.0) .05
Neoadjuvant chemotherapy 67 (26.0) 56 (37.1) 30 (36.6) .03
Perioperative outcomes
ORT, mean (SD), min 450.8 (121.0) 388.5 (76.7) 348.6 (52.6) <.001
Conversion 18 (7.0) 7 (4.6) 0 .006
EBL, mean (SD), mL 426.6 (525.8) 288.6 (335.0) 254.7 (274.1) <.001
pRBC units transfused 47 (18.2) 17 (11.3) 6 (7.3) .02
Pathology
PDA 129 (50.0) 80 (53.0) 37 (45.1) .46
AMP 41 (15.9) 16 (10.6) 14 (17.1)
IPMN 33 (12.8) 13 (8.6) 11 (13.4)
NET 17 (6.6) 13 (8.6) 8 (9.8)
CCA 16 (6.2) 15 (9.9) 3 (3.7)
Other 22 (8.5) 14 (9.3) 9 (11.0)
PV isolation clamp 41 (15.9) 32 (21.2) 8 (9.8) .07
Concomitant procedure 4 (1.6) 6 (4.0) 5 (6.1) .09
Tumor size, mean (SD), cm 2.8 (1.5) 2.7 (1.4) 2.8 (1.4) .88
Positive margin 35 (13.6) 18 (11.9) 7 (8.5) .45
Total nodes, mean (SD) 27.4 (13.4) 30.8 (10.0) 34.0 (13.7) <.001
Postoperative outcomes
Wound infection 31 (12.1) 21 (13.9) 11 (13.4) .85
CR-POPF 21 (8.1) 11 (7.3) 5 (6.1) .82
Any Clavien-Dindo complication 180 (69.8) 103 (68.2) 50 (61.0) .34
Clavien-Dindo >2 complications 74 (28.7) 30 (19.9) 12 (14.6) .01
Length of stay, mean (SD), d 11.0 (9.3) 9.7 (7.0) 8.1 (7.2) <.001
Readmission within 90 d 94 (37.2) 46 (31.7) 30 (40.0) .40
Mortality within 90 d 7 (2.8) 5 (3.4) 2 (2.7) .93

Abbreviations: AMP, ampullary; ASA, American Society of Anesthesiologists; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CCA, cholangiocarcinoma; CR-POPF, clinically relevant post-operative pancreatic fistula; EBL, estimated blood loss; IPMN, intrapapillary mucinous neoplasm; NET, pancreatic neuroendocrine tumor; ORT, operating room time; PDA, pancreatic ductal adenocarcinoma; pRBC, packed red blood cells; PV, portal vein.

a

Statistically significant values at P less than .05.